(Q30369228)

English

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 June 2017

1 reference

based on heuristic

inferred from title

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial. (English)

1 reference

Europe PubMed Central

21 June 2017

phase I clinical trial

0 references

Marco Goeijenbier

2

object named as

Marco Goeijenbier

0 references

15

object named as

Albert D M E Osterhaus

1 reference

Europe PubMed Central

21 June 2017

object named as

Gerd Sutter

14

0 references

11

object named as

Ron A M Fouchier

1 reference

Europe PubMed Central

21 June 2017

Guus Rimmelzwaan

13

object named as

Guus F Rimmelzwaan

1 reference

Europe PubMed Central

21 June 2017

10

object named as

Asisa Volz

1 reference

Europe PubMed Central

21 June 2017

Eric C. M. van Gorp

12

object named as

Eric C M van Gorp

1 reference

Europe PubMed Central

21 June 2017

Joost H C M Kreijtz

1

object named as

Joost H C M Kreijtz

1 reference

Europe PubMed Central

21 June 2017

author name string

Fleur M Moesker

3

1 reference

Europe PubMed Central

21 June 2017

Lennert van den Dries

4

1 reference

Europe PubMed Central

21 June 2017

Simone Goeijenbier

5

1 reference

Europe PubMed Central

21 June 2017

Heidi L M De Gruyter

6

1 reference

Europe PubMed Central

21 June 2017

Michael H Lehmann

7

1 reference

Europe PubMed Central

21 June 2017

Gerrie de Mutsert

8

1 reference

Europe PubMed Central

21 June 2017

David A M C van de Vijver

9

1 reference

Europe PubMed Central

21 June 2017

publication date

30 October 2014

1 reference

Europe PubMed Central

21 June 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Lancet Infectious Diseases

1 reference

Europe PubMed Central

21 June 2017

14

1 reference

Europe PubMed Central

21 June 2017

12

1 reference

Europe PubMed Central

21 June 2017

1196-1207

1 reference

Europe PubMed Central

21 June 2017

A pandemic warning?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical vaccine development for H5N1 influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

H5N1 vaccines in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Airborne transmission of influenza A/H5N1 virus between ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical development of Modified Vaccinia virus Ankara vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant MVA vaccines: dispelling the myths

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Smallpox vaccines: targets of protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970963-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(14)70963-6

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30369228&oldid=1872433693"